Literature DB >> 12631075

Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells.

Bing-Fen Liu1, Satoshi Miyata, Yushi Hirota, Satomi Higo, Hiroyuki Miyazaki, Michiru Fukunaga, Yasuhiro Hamada, Shigemitsu Ueyama, Osamu Muramoto, Atsuko Uriuhara, Masato Kasuga.   

Abstract

BACKGROUND: The formation of methylglyoxal (MG), a highly reactive dicarbonyl compound, is accelerated through several pathways, including the glycation reaction under diabetic conditions, presumably contributing to tissue injury in diabetes. On the other hand, apoptotic cell death of glomerular cells has been suggested to play a role in the development of glomerulosclerosis in various types of glomerular injuries. We therefore examined whether MG was capable of inducing apoptosis in rat mesangial cells to address the possible mechanism by which hyperglycemia-related products accelerated pathologic changes in diabetic glomerulosclerosis.
METHODS: Rat mesangial cells were incubated with 0 to 400 micromol/L MG, followed by the detection of apoptosis by both TUNEL method and electrophoretic analysis for DNA fragmentation. In addition, we investigated intracellular mechanisms mediating MG-induced apoptosis, focusing especially on the p38 mitogen-activated protein kinase (MAPK) pathway.
RESULTS: MG induced apoptosis in rat mesangial cells in a dose-dependent manner and was accompanied by the activation of p38alpha isoform. Aminoguanidine and N-acetyl-l-cysteine inhibited the MG-induced p38 MAPK activation, as well as apoptosis in rat mesangial cells, suggesting the involvement of oxidative stress in these phenomena. SB203580, a specific inhibitor of p38 MAPK also suppressed the MG-induced apoptosis in rat mesangial cells.
CONCLUSIONS: These results suggest a potential role for MG in glomerular injury through p38 MAPK activation under diabetic conditions and may serve as a novel insight into the therapeutic strategies for diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631075     DOI: 10.1046/j.1523-1755.2003.00829.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2'-deoxyguanosine in human cells.

Authors:  Daniel Tamae; Punnajit Lim; Gerald E Wuenschell; John Termini
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

2.  Role of methylglyoxal in essential hypertension.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

3.  Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

Authors:  Mani Alikhani; Zoubin Alikhani; Coy Boyd; Christine M MacLellan; Markos Raptis; Rongkun Liu; Nicole Pischon; Philip C Trackman; Louis Gerstenfeld; Dana T Graves
Journal:  Bone       Date:  2006-10-24       Impact factor: 4.398

4.  Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity.

Authors:  Xiao-Liang Wang; Wayne B Lau; Yue-Xing Yuan; Ya-Jing Wang; Wei Yi; Theodore A Christopher; Bernard L Lopez; Hui-Rong Liu; Xin-Liang Ma
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-11       Impact factor: 4.310

5.  The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal.

Authors:  Julie Webster; Christin Urban; Katrin Berbaum; Claudia Loske; Alan Alpar; Ulrich Gärtner; Susana Garcia de Arriba; Thomas Arendt; Gerald Münch
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions.

Authors:  Ambra Pozzi; Roy Zent; Sergei Chetyrkin; Corina Borza; Nada Bulus; Peale Chuang; Dong Chen; Billy Hudson; Paul Voziyan
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

7.  A High-Throughput Targeted Proteomic Approach for Comprehensive Profiling of Methylglyoxal-Induced Perturbations of the Human Kinome.

Authors:  Weili Miao; Yongsheng Xiao; Lei Guo; Xiaogang Jiang; Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2016-09-22       Impact factor: 6.986

8.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Authors:  Weijing Cai; Maya Ramdas; Li Zhu; Xue Chen; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

9.  Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.

Authors:  Yi Guo; Yuning Zhang; Xunjun Yang; Panpan Lu; Xijuan Yan; Fanglan Xiao; Huaibin Zhou; Chaowei Wen; Mengru Shi; Jianxin Lu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

Review 10.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.